<DOC>
	<DOCNO>NCT00331981</DOCNO>
	<brief_summary>Primary purpose : - To find effective long term treatment amisulpride positive negative symptom schizophrenic patient - To find safe long term treatment amisulpride schizophrenic patient Secondary purpose : - To find effective long term treatment amisulpride quality life schizophrenic patient - To find effective long term treatment amisulpride cognitive function schizophrenic patient</brief_summary>
	<brief_title>Amisulpride Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Patients diagnose schizophrenia schizophrenic disorder accord DSMIV Patients need new antipsychotic drug need change medication due aggravation symptom recurrence Patients positive symptom disorder correspond schizophrenic criterion . ( e.g , schizoaffective disorder ) Patients hypersensitive active ingredient ingredient study drug Prolactindependant tumor , pituitary gland prolactinomas breast cancer Pheochromocytoma Parkinson 's disease Pregnancy breast feed Current recently withdraw drug abuse alcoholism Chronic renal failure internal surgical disease physician decides worsen trial medication affect metabolism effect trial medication Patients previous history clinical improvement see spite treatment 2 antipsychotic 8 week Slow heart rate &lt; 55bpm , low blood potassium level , congenital prolongation QT interval Current treatment drug likely cause markedly slow heart rate ( &lt; 55bpm ) , low blood potassium level , slow intercardiac condition prolongation QT interval The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>